908 Devices Inc. 8-K

What Happened

• 908 Devices Inc. announced it completed the acquisition of NIRLAB SA and its subsidiary (the NIRLAB Group) on May 4, 2026. NIRLAB develops near-infrared (NIR) spectroscopy solutions for instant material identification. The board approved the transaction and the Company issued a press release and investor presentation on May 6, 2026 and announced first-quarter results for the period ended March 31, 2026.

Key Details

• Purchase headline price: $15,000,000 (the “Preliminary Consideration”) consisting of $13,000,000 cash plus 293,368 shares of 908 Devices common stock. Cash subject to customary adjustments.
• Holdbacks: $1,300,000 of cash and 10% of the stock consideration withheld (General Holdback Amount) to secure post-closing obligations; subject to release 12 months after closing (absent claims).
• Earn-out: up to $8,000,000 payable solely in 908 Devices shares based on revenue milestones through December 31, 2027.
• Closing and parties: transaction closed May 4, 2026; sellers include Florentin Coppey, Pierre Esseiva, Matteo Delbrück, Parkview Invest AG and Matthieu Girod. All 1,094,282 NIRLAB shares were acquired.
• Options and lock-ups: 36,750 NIRLAB options were cancelled and settled (cash/stock as applicable). Sellers and option holders agreed to a 180-day lock-up on Company shares received. Sellers also agreed to 3-year non-compete and non-solicit covenants.
• Agreement filings: the Share Purchase Agreement is filed as Exhibit 2.1 to the Form 8-K (certain confidential portions redacted).

Why It Matters

• The deal brings NIR spectroscopy technology into 908 Devices’ product mix, potentially expanding its identification and analytical offerings in markets that use instant material ID. The transaction used a mix of cash and equity, meaning a near-term cash outflow (~$13M before adjustments) and issuance of 293,368 shares, with possible further share issuance if earn-outs are met. Investors should note the holdbacks, lock-ups, indemnities and earn-out structure, all of which affect timing of payments, potential dilution and how future performance of the acquired business will be measured.